Lri Investments, LLC Axsome Therapeutics, Inc. Transaction History
Lri Investments, LLC
- $1.18 Trillion
- Q2 2025
A detailed history of Lri Investments, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Lri Investments, LLC holds 23 shares of AXSM stock, worth $3,062. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23Holding current value
$3,062% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AXSM
# of Institutions
412Shares Held
37.4MCall Options Held
710KPut Options Held
541K-
Vanguard Group Inc Valley Forge, PA3.95MShares$525 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$439 Million0.01% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$225 Million6.93% of portfolio
-
Rtw Investments, LP New York, NY1.52MShares$202 Million2.43% of portfolio
-
Macquarie Group LTD Australia, C31.14MShares$151 Million0.15% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.71B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...